ExoCoBio Company
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.
.png)
Technology:
Regenerative Medicine
Industry:
Small&Large Molecules
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2017
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
16
Total Funding:
$47 000 000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-08-25
Last Funding Type:
Series C
Register and Claim Ownership